This report describes for the first time the association of Beckwith-Wiedemann syndrome (BWS) and hypothyroidism in a 25 weeks preterm neonate. Antenatal diagnosis of exomphalos in association with postnatal transient hypoglycemia and macroglossia formed the basis of the diagnosis of BWS. Primary hypothyroidism was detected on routine Guthrie card examination. Molecular DNA analysis demonstrated biparental inheritance of chromosome 11p15.5. Dosage analysis of differently methylated region showed evidence of loss of maternal methylation at KvDMR1.
Case report A male infant was born prematurely at 25 weeks gestation weighing 830 g (50th centile) to unrelated Black Caribbean parents. The infant's mother was 34 years old and had previously lost an infant at 2 days of age as a result of group B streptococcus septicemia. An exomphalos was detected on the 20-week anomaly ultrasound scan, which contained bowel and mesentery. There were no other major malformations (Figures 1a and b) . At delivery, the Apgar score was 7 and 9 at 1 and 5 min, respectively. The infant was electively intubated and surfactant was administered.
After birth, an exomphalos minor was confirmed. Further examination revealed macroglossia, but no other organomegaly. Detailed echocardiogram revealed no structural heart abnormalities. Abdominal ultrasound scan demonstrated normal liver size and texture and normal kidneys.
The blood glucose level was <2 mmol l À1 . The infant was treated for hypoglycemia in the first few days of life. He required increasing concentrations of glucose infusion up to 20 mg kg À1 min À1 to maintain euglycemia. Initially, the infant was on conventional ventilation. However, as a result of worsening lung disease, high frequency oscillation was used till his care was withdrawn at 25 days of life. Respiratory deterioration was compounded by a large 2.4 mm persistent ductus arteriosus, which failed to close despite two courses of ibuprofen therapy. Vasopressor resistant hypotension required maximal ionotropic support and parenteral hydrocortisone. The infant developed acute renal failure with rising serum potassium levels and low urine output, which was treated by an intravenous infusion of salbutamol, insulin/dextrose, calcium resonium and sodium bicarbonate. He developed late onset coagulase negative staphylococcus septicemia with meningitis on day 12 of life; this was treated with intravenous vancomycin and piptazobactam. He remained on total parenteral nutrition and never established entral feeds. On day 14 of life he developed 2:1 heart block. Thyroid function tests were requested. These revealed high thyroid stimulating hormone (TSH) levels of >100 mU l À1 and low levels of triiodothyronine (T3; 3 pmol l À1 ), which is indicative of primary hypothyroidism. He was started on an intravenous infusion of T3. High blood spot TSH concentration of 83 mU l À1 , equivalent to 160 mU l À1 plasma (normal range up to 10 mU l À1 ) was also detected on routine Guthrie card examination, confirming the presence of congenital hypothyroidism. There was no history of thyroid disease in his pedigree.
In view of the significant deterioration in the infants' clinical condition, his care was withdrawn on day 25 of life. Chromosomal analysis revealed normal male karyotype. Molecular DNA analysis using polymerase chain reaction (PCR) demonstrated biparental inheritance of chromosome 11p15.5 with no evidence of mosaic isodisomy. Dosage analysis of differently methylated region showed evidence of loss of maternal methylation at KvDMR1 consistent with a diagnosis of Beckwith-Wiedemann syndrome (BWS). Molecular analysis was performed by PCR amplification of the KvDMR1 region following bisulfite treatment. The PCR product was digested with the restriction enzyme, BstU1, to enable differentiation between the parental alleles. The digested products were resolved by gel electrophoresis. Postmortem examination was declined by parents.
Literature review
Inheritance of BWS syndrome is complex. Possible patterns include autosomal dominant inheritance with variable expressivity, contiguous gene duplication at 11p15 and genomic imprinting resulting from a defective or absent copy of the maternally derived gene. 1, 2 The characteristic features of BWS are variable, but mainly consist of macroglossia, fusion defects of the abdominal wall, somatic gigantism, midface hypoplasia, ear creases and/or pits, nevus flammeus, visceromegaly, cryptochidism and hemihypertrophy. 3 The acronym EMG syndrome was used earlier to describe exomphalos, macroglossia and gigantism. Hypoglycemia, which is usually transient, can also occur in the first few days of life. 4 Most cases of BWS are sporadic, although the occurrence of the phenotype has been observed in twins and subtle features of the syndrome like hemihypertrophy has been described in families of affected patients. 5 This phenomenon of incomplete penetrance has been described in the literature. In one report of 68 apparently sporadic cases, 15 had a relative with minor features of the syndrome. Some of the characteristic features of the syndrome may not be detected at birth, but develop later in life. 6 BWS patients are at increased risk of developing malignant tumors, mainly Wilm's tumor and adrenal carcinoma, with an incidence of 7.5%. 7 To our knowledge, this is the fourth report in the literature of a case of BWS associated with congenital hypothyroidism and the first to be described in an extremely preterm neonate. The initial description of the association of the syndrome with hypothyroidism was reported in 1985 by Martínez et al., who presented a family of six siblings, in whom four were affected with BWS and one had congenital hypothyroidism. The latter was diagnosed early in infancy and was successfully treated. 8 Four years later, Sippell et al. 9 reported seven patients with EMG syndrome, one of whom had latent hypothyroidism. In 1990, congenital hypothyroidism was described in one sibling of a monozygotic diamniotic twin born at term. The infant was diagnosed at day 3 of life with BWS 10 (Table 1 ). In addition, three other reports have described the association of BWS with different thyroid-related biochemical derangements in absence of hypothyroidism. Vidaihet et al.
11 described four infants with EMG syndrome who had low I 131 uptake with normal levels of protein bound iodine. Kaufmann and Frederickson, and Leung et al. reported two patients with BWS syndrome who had thyroxinbinding globulin deficiency. These, however, were not associated with hypothyroidism.
12,13
Discussion Our report is the first to describe the association of BWS and hypothyroidism in a preterm neonate. This case created a diagnostic challenge particularly that the presentation of hypothyroidism in preterm infants could be difficult to elucidate clinically. BWS was considered in the context of exomphalos, macroglossia and initial hypoglycemia with thyroid dysfunction suspected when the infant developed heart block.
Despite being adequately treated with thyroid replacement therapy as evident by normalization of serum TSH and thyroxin levels, the infant succumbed in the early neonatal period mainly because of complications relating to prematurity. However, deterioration secondary to the hypothyroidism could not be ruled out. It is well known that transient hypothyroxinemia (that is, low serum thyroxin and normal TSH levels) in sick preterm neonates is associated with illness severity and poor outcome.
14 It is plausible that the persistent pattern of thyroid dysfunction in this infant might have contributed to the poor outcome. Molecular confirmation of the syndrome was available after the infant's death; thus it was not possible to explore further genetic mutations in relation to congenital hypothyroidism.
It has been postulated that the gene governing the production of thyroxin-binding globulin might be in close proximity with the one that governs the production of thyroxin and may well be linked closely to the gene that suppresses the manifestations of BWS. 15, 16 As reports of the association of BWS with congenital hypothyroidism accumulate in the literature, interest in exploring the pathogenetic link between the two conditions will rise.
We believe preterm infants suspected of having BWS should have their thyroid function status checked soon after birth. A delay in diagnosing thyroid dysfunction in this group of infants might have a detrimental effect on their survival and long-term outcome.
